Clean Science and Technology Limited will host a conference call on August 1, 2026, to discuss the unaudited financial results for the quarter ended June 30, 2026. The earnings call is scheduled for 4:00 P.M. IST and will provide analysts and investors with an overview of the company's performance in Q1FY27.

The disclosure was made to BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is also available on the company's official website.

The management team will be represented by senior executives, including Mr. Siddhartha Sikchi, Promoter and Managing Director; Mr. Sanjay Parnerkar, Chief Financial Officer; and Mr. Pratik Bora, President, Commercial. They will address queries regarding the financial results.

Participants can join the call using the universal access numbers +91 22 6280 1145 or +91 22 7115 8046. Diamond Pass registration is available for interested attendees.

For further information, stakeholders may contact Mr. Pratik Bora via phone at 7888009680 or email at pratik@cleanscience.co.in .

Clean Science and Technology Limited’s wholly owned subsidiary, Clean-Fino Chem Limited, has entered into a definitive agreement for a long-term strategic collaboration with Geneus Chem AG, a company incorporated under the laws of Switzerland. The partnership aims to support the specialty chemicals portfolio of Clean Science and Technology Limited through the exclusive worldwide manufacture of advanced grades of HALS products. The manufacturing operations will be undertaken domestically, with products sold in both domestic and international markets.

The collaboration agreement was executed on July 16, 2026, between Clean-Fino Chem Limited, Geneus Chem AG, and the co-founders of the Swiss entity. The definitive agreements include provisions for minimum offtake commitments, a pricing mechanism, product specifications, and non-compete obligations. Lodha Capital Markets Ltd acted as the financial advisor, while AZB & Partners served as the legal advisor for the transaction.

In consideration for the manufacturing and supply agreement, Geneus Chem AG has agreed to issue share warrants to Clean-Fino Chem Limited. These warrants are exercisable within a period of four years from the date of issuance. Upon exercise, the subsidiary will acquire a 25% stake in the share capital of Geneus Chem AG on a fully diluted basis. No consideration is payable by the subsidiary for the subscription to these share warrants, though a nominal price per share will be required upon exercise.

Geneus Chem AG, incorporated in 2022, is currently a start-up not operating at a significant scale in terms of revenue. The company is engaged in the research, development, and trading of chemical products, with a specific focus on advanced grades of HALS Products. The transaction does not constitute a related party transaction, and no governmental or regulatory approvals are required for the acquisition.

The strategic move aligns with the company’s broader business strategy to enhance its offerings in the specialty chemicals sector. The consideration for manufacturing services will be determined based on a pricing formula agreed upon between the parties involved.

Key Details of the Collaboration